Author

Sheng Kuang

Maastricht University

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1

Frequent Co-Authors

Ala YarominaiD· 1 shared Alexander Marie-Madeleine Adrianus van der WieliD· 1 shared Èlia Prades-SagarraiD· 1 shared Jan TheysiD· 1 shared Jennifer JungiD· 1 shared Jeremy S. SettoniD· 1 shared Kim Rosalie KampeniD· 1 shared Lesley SchuitmakeriD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Ala YarominaORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Deficiencies in the Fanconi Anemia or the Homologous Recombination Pathway enhance the antitumor effects of the novel hypoxia-activated prodrug CP-506

Lesley Schuitmaker, Alexander Marie-Madeleine Adrianus van der Wiel, Natasja G. Lieuwes, Rianne Biemans, Nikki A.M. Mutsters, Jennifer Jung, Victoria Claudino Bastos, Èlia Prades-Sagarra, Sheng Kuang, Jeremy S. Setton, Sabine A. S. Langie, Kim Rosalie Kampen, Jan Theys, Ala Yaromina, Ludwig Jerome Dubois, Philippe Lambin

This study shows that deficiencies in Fanconi Anemia or homologous recombination pathways enhance the antitumor effects of CP-506, a hypoxia-activated prodrug, through synthetic lethality mechanisms.

Molecular Therapy Oncology · Feb 24, 2026Peer-reviewedCancer Biology